Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 7OTHER 3FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Itraconazole 3Golytely 3Cryotherapy 3Colonoscopy 3Decision Support Techniques 2Capecitabine 2gadolinium ethoxybenzyl DTPA 1Water 1Surveys and Questionnaires 1Surgical Instruments 1Standard of Care 1Simvastatin 1Reference Standards 1Radiofrequency Ablation 1Quality Improvement 1Proctectomy 1Methods 1Mass Screening 1Infliximab 1Indigo Carmine 1Hydroxychloroquine 1Folic Acid 1Ethiodized Oil 1Endoscopy, Digestive System 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1DNA Primers 1Cryosurgery 1Control Groups 1Congresses as Topic 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × ADI PEG20 × Gastrointestinal × Clear all
NCT00056992 2015-03-25

Testing of ADI-PEG in Hepatocellular Carcinoma

FDA Office of Orphan Products Development

Phase 2 Completed
34 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡